Table of Contents: Who should not take semaglutide
When to Seek Medical Advice During Treatment Seek same-day medical assessment if you develop fever, rigors, or back pain during retatrutide treatment, and report all new symptoms to your trial team as required by clinical trial protocol
Type 3: electrolyte depletion fatigue What it feels like: Muscle heaviness, mild cramping, and a specific kind of weakness that rest alone does not fix
Does not require stomach acid for absorption, making it the superior choice for GLP-1 users since these medications reduce stomach acid production and slow gastric emptying
As GLP-1 drugs reshape the global weight-loss industry, the reaction to Williams Super Bowl ad shows a growing discomfort: when icons endorse prescription medicine on the biggest stage in advertising, the conversation quickly shifts from health to responsibility and who should be shaping it.
Whilst early results are promising, retatrutide is not approved for clinical use , and any claims about its effects outside of peer-reviewed trial data should be viewed critically
%25201.png)
